DKDániel Krakkó

Dániel Krakkó

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dániel Krakkó has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Andras Perl

    State University of New York, Upstate Medical University, College of Medicine

    4 shared publications
  • Sándor Dóbé

    Renewable Energy Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, H-1117, Budapest, Magyar tudósok körútja 2, Hungary

    4 shared publications
  • Akshay Patel

    Departments of Medicine, State University of New York, Norton College of Medicine, Syracuse, USA

    3 shared publications
  • Gyula Záray

    3 shared publications
  • Tamas Faludi

    Departments of Medicine, State University of New York, Norton College of Medicine, Syracuse, USA

    3 shared publications
  • Viktória Licul-Kucera

    Laboratory for Environmental Chemistry and Bioanalytics, Institute of Chemistry, ELTE - Eötvös Loránd University, H-1117, Budapest, Pázmány Péter Sétány 1/A, Hungary; Cooperative Research Center for Environmental Sciences, ELTE - Eötvös Loránd University, H-1117, Budapest, Pázmány Péter Sétány 1/A, Hungary

    3 shared publications

Latest Publications

  • Top Cited Papers
    Open Access

    Implementing Annotation Confidence Scoring in Untargeted Mass Spectrometry Workflows for Small Molecule Analysis

    by Daniel Krakko, Ralf Tautenhahn, Whitney L. Stutts

    Untargeted small molecule analysis by high-resolution mass spectrometry is integral to environmental and biological research, enabling comprehensive characterization of complex samples. However, data interpretation and reporting remain challenging due to the complexity and high dimensionality of molecular features in untargeted data sets. Current data analysis platforms provide integrated tools for processing and annotation yet lack a standardized framework for assigning and reporting annotation confidence. Communicating varying levels of confidence in untargeted data sets continues to pose challenges without an automated ranking system. To address this, a custom scripting node was developed that assigns annotation confidence levels based on the widely adopted Schymanski et al. scoring scheme. While implemented here for metabolomics, the scoring approach is broadly applicable to other untargeted small molecule workflows. The script can be incorporated into a commercial data analysis software package and functions as a standalone postprocessing node, expanding the original five-level system with four new sublevels (levels 3a/3b and 4a/4b) to improve specificity and distinguish cases that fall between established categories. Annotation confidence is assessed using available information from all compound identification workflow nodes (e.g., Predicted Composition, mzVault, mzCloud, ChemSpider), and the consensus scoring algorithm is used to evaluate agreement among search nodes for greater accuracy. Validation using NIST SRM 1950 plasma samples demonstrated 100% scoring accuracy in negative mode and >99.5% in positive mode across both RPLC and HILIC separations. This tool enhances data reporting, improves transparency, and promotes consistency across studies, facilitating standardization and comparability of untargeted metabolomics results.


  • Open Access

    Conditional knockout of C/EBPβ in epidermis results in dysregulated lipid biosynthesis and a defect in skin barrier function

    by Kevin J. Mills, Michael Doyle, John S. House, John G. Witherspoon, Daniel Krakko, Whitney L. Stutts, Jessie R. Chappel, Jonathan R. Hall, Erin S. Baker, Robert C. Smart

    CCAAT/enhancer binding protein- β (C/EBP β ) is a basic leucine zipper transcription factor that is abundantly expressed in epidermal keratinocytes of skin. In the present study, C/EBP β epidermal specific conditional knockout (CKO β ) SKH1 mice were utilized to interrogate C/EBP β ’s role in lipid biosynthesis and skin barrier integrity. RNAseq data analysis and gene set enrichment analysis of RNA isolated from the epidermis of CKO β and K5Cre control mice revealed that deletion of C/EBP β in epidermis resulted in an enrichment of downregulated genes in gene sets associated with lipid metabolism. Further analysis showed the majority of differentially regulated genes were downregulated in gene sets related to the metabolism/biosynthesis of ceramides, fatty acids, phospholipids, sphingolipids, and cholesterol species in CKO β epidermis. Ingenuity Pathway Analysis predicted inhibition of multiple pathways involving lipid biosynthesis. Lipidomic analysis of epidermis using advanced chemical separations and tandem mass spectrometry identified 470 individual lipids in epidermis with 165 significantly decreased and 82 significantly increased in CKO β epidermis. The lysophospholipids were the most decreased class of lipids, and free fatty acids and ceramides important in barrier formation were also decreased. The sphingomyelin class of lipids was the most increased. High resolution mass spectrometry for cholesterol lipids revealed several cholesterol esters were also dysregulated in CKO β epidermis. Finally, we assessed the functional consequences of the loss C/EBP β on epidermal barrier function and found that basal permeability barrier function as measured by transepidermal water loss (TEWL) was impaired, with an approximate doubling of TEWL in CKO β mice. These results indicate that C/EBP β is a is a major regulator of the epidermal lipidome and the deletion of C/EBP β in epidermis leads to a defect in skin barrier function.

  • Open Access

    Rab4a Drives Proinflammatory CD4+ T Cell Signaling via CD38-Dependent NAD+ Metabolism

    by Andras Perl, Joy Park, Daniel Krakko, Jessica Nolan, Brandon Wyman, Mahsa Sadeghzadeh

    Rab4A, a small GTPase overexpressed in T cells of patients with systemic lupus erythematosus (SLE), has been shown to activate mechanistic target of rapamycin (mTOR) signaling, which promotes proinflammatory T cell development and predisposes to nephritis in SLE. In this study, we demonstrate that Rab4A facilitates the endocytic recycling and surface expression of CD38, which, in turn, triggers NAD+ depletion, activates mTOR complex 1, and suppresses interleukin-2 (IL-2) production in CD4+ T cells. Rab4A-driven CD38-mediated NAD+ depletion elicits the accumulation of nicotinamide and ADP-ribose and secondary depletion of cyclic ADP-ribose. Surprisingly, rapamycin further enhanced CD38 expression and reduced IL-2 secretion, suggesting that IL-2 depletion is mTOR-independent. Alternatively, Rab4A-driven upregulation of CD38 promoted STAT3 expression and its acetylation, as well as FOXO1 expression, which underlies IL-2 depletion in CD4+ T cells. These findings reveal a novel Rab4A-driven CD38 signaling axis that links receptor trafficking to proinflammatory metabolic pathways, providing new targets for treatment in SLE.


  • Top Cited Papers
    Open Access

    Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation

    by Nick Huang, Thomas Winans, Brandon Wyman, Zachary Oaks, Tamas Faludi, Gourav Choudhary, Zhi-Wei Lai, Joshua Lewis, Miguel Beckford, Manuel Duarte, et al.

    Activation of the mechanistic target of rapamycin (mTOR) is a key metabolic checkpoint of pro-inflammatory T-cell development that contributes to the pathogenesis of autoimmune diseases, such as systemic lupus erythematosus (SLE), however, the underlying mechanisms remain poorly understood. Here, we identify a functional role for Rab4A-directed endosome traffic in CD98 receptor recycling, mTOR activation, and accumulation of mitochondria that connect metabolic pathways with immune cell lineage development and lupus pathogenesis. Based on integrated analyses of gene expression, receptor traffic, and stable isotope tracing of metabolic pathways, constitutively active Rab4AQ72L exerts cell type-specific control over metabolic networks, dominantly impacting CD98-dependent kynurenine production, mTOR activation, mitochondrial electron transport and flux through the tricarboxylic acid cycle and thus expands CD4+ and CD3+CD4−CD8− double-negative T cells over CD8+ T cells, enhancing B cell activation, plasma cell development, antinuclear and antiphospholipid autoantibody production, and glomerulonephritis in lupus-prone mice. Rab4A deletion in T cells and pharmacological mTOR blockade restrain CD98 expression, mitochondrial metabolism and lineage skewing and attenuate glomerulonephritis. This study identifies Rab4A-directed endosome traffic as a multilevel regulator of T cell lineage specification during lupus pathogenesis.


  • Open Access

    Publisher Correction: Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis

    by Z. Oaks, A. Patel, N. Huang, G. Choudhary, T. Winans, T. Faludi, D. Krakko, M. Duarte, J. Lewis, M. Beckford, et al.

  • Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis

    by Z. Oaks, A. Patel, N. Huang, G. Choudhary, T. Winans, T. Faludi, D. Krakko, M. Duarte, J. Lewis, M. Beckford, et al.

    Oxidative stress modulates carcinogenesis in the liver; however, direct evidence for metabolic control of oxidative stress during pathogenesis, particularly, of progression from cirrhosis to hepatocellular carcinoma (HCC), has been lacking. Deficiency of transaldolase (TAL), a rate-limiting enzyme of the non-oxidative branch of the pentose phosphate pathway (PPP), restricts growth and predisposes to cirrhosis and HCC in mice and humans. Here, we show that mitochondrial oxidative stress and progression from cirrhosis to HCC and acetaminophen-induced liver necrosis are critically dependent on NADPH depletion and polyol buildup by aldose reductase (AR), while this enzyme protects from carbon trapping in the PPP and growth restriction in TAL deficiency. Both TAL and AR are confined to the cytosol; however, their inactivation distorts mitochondrial redox homeostasis in opposite directions. The results suggest that AR acts as a rheostat of carbon recycling and NADPH output of the PPP with broad implications for disease progression from cirrhosis to HCC.


  • Open Access

    UV and (V)UV irradiation of sitagliptin in ultrapure water and WWTP effluent: Kinetics, transformation products and degradation pathway

    by Dániel Krakkó, Ádám Illés, Attila Domján, Attila Demeter, Sándor Dóbé, Gyula Záray


  • Open Access

    Application of (V)UV/O3 technology for post-treatment of biologically treated wastewater: A pilot-scale study

    by Dániel Krakkó, Ádám Illés, Viktória Licul-Kucera, Bence Dávid, Péter Dobosy, Andrea Pogonyi, Attila Demeter, Victor G. Mihucz, Sándor Dóbé, Gyula Záray


  • Laponite immobilized TiO2 catalysts for photocatalytic degradation of phenols

    by Erzsébet Décsiné Gombos, Dániel Krakkó, Gyula Záray, Ádám Illés, Sándor Dóbé, Ágnes Szegedi


  • Enhanced photolytic and photooxidative treatments for removal of selected pharmaceutical ingredients and their degradation products in water matrices

    by Dániel Krakkó, Erzsébet Gombos, Viktória Licul-Kucera, Sándor Dóbé, Victor G. Mihucz, Gyula Záray